Showing promise in the landscape of excess body fat therapy, retatrutide presents a unique approach. Different from many existing medications, retatrutide operates as a double agonist, simultaneously targeting both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) binding sites. This simultaneous stimulation fosters multipl… Read More